Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin S Channer

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Endocrinology|August 7, 2004
A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 menPaul D Morris, Chris J Malkin, Kevin S Channer, et al.
Clinical Science (London, England : 1979)|March 3, 2004
Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism actionRichard D Jones, Kate M English, T Hugh Jones, et al.
Circulation|November 7, 2007
Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptorJoanne E Nettleship, T Hugh Jones, Kevin S Channer, et al.
European Journal of Endocrinology|September 4, 2013
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetesVakkat Muraleedharan, Hazel Marsh, Dheeraj Kapoor, et al.
British Journal of Pharmacology|March 19, 2003
The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?Richard D Jones, Peter J Pugh, T Hugh Jones, et al.
Diabetes Care|March 30, 2007
Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposityDheeraj Kapoor, Hazel Aldred, Stephanie Clark, et al.
Endocrine Research|December 20, 2002
Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factorsPeter J Pugh, Kevin S Channer, Helen Parry, et al.
European Journal of Endocrinology|January 22, 2003
Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouseRichard D Jones, Peter J Pugh, Joanne Hall, et al.
Age and Ageing|December 19, 2006
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)Amar Rash, Tom Downes, Robin Portner, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 20, 2005
Testosterone and atherosclerosis in aging men: purported association and clinical implicationsRichard D Jones, Joanne E Nettleship, Dheeraj Kapoor, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Endocrinology|August 7, 2004
A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 menPaul D Morris, Chris J Malkin, Kevin S Channer, et al.
Clinical Science (London, England : 1979)|March 3, 2004
Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism actionRichard D Jones, Kate M English, T Hugh Jones, et al.
Circulation|November 7, 2007
Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptorJoanne E Nettleship, T Hugh Jones, Kevin S Channer, et al.
European Journal of Endocrinology|September 4, 2013
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetesVakkat Muraleedharan, Hazel Marsh, Dheeraj Kapoor, et al.
British Journal of Pharmacology|March 19, 2003
The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?Richard D Jones, Peter J Pugh, T Hugh Jones, et al.
Diabetes Care|March 30, 2007
Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposityDheeraj Kapoor, Hazel Aldred, Stephanie Clark, et al.
Endocrine Research|December 20, 2002
Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factorsPeter J Pugh, Kevin S Channer, Helen Parry, et al.
European Journal of Endocrinology|January 22, 2003
Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouseRichard D Jones, Peter J Pugh, Joanne Hall, et al.
Age and Ageing|December 19, 2006
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)Amar Rash, Tom Downes, Robin Portner, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 20, 2005
Testosterone and atherosclerosis in aging men: purported association and clinical implicationsRichard D Jones, Joanne E Nettleship, Dheeraj Kapoor, et al.
Pageof 6